4//SEC Filing
Arch Therapeutics, Inc. 4
Accession 0001144204-17-006091
CIK 0001537561operating
Filed
Feb 5, 7:00 PM ET
Accepted
Feb 6, 11:26 AM ET
Size
7.2 KB
Accession
0001144204-17-006091
Insider Transaction Report
Form 4
DAVIS RICHARD E
CFO & TREASURER
Transactions
- Award
Common Stock
2017-02-03+500,000→ 603,000 total - Award
Stock Option (right to buy)
2017-02-03+500,000→ 500,000 totalExercise: $0.65Exp: 2027-02-02→ Common Stock (500,000 underlying)
Footnotes (2)
- [F1]Of the Shares subject to this grant, all are issued pursuant to the 2013 Stock Incentive Plan (the "Plan") and 100% shall fully vest on the second anniversary of the date of grant. In addition, in the event of a Change of Control (as such term is defined in the Plan) 100% of grant will immediately vest.
- [F2]Of the Shares subject to this Grant, 25% shall vest immediately and 1/36 of the remaining shares shall vest on each of the next thirty-six (36) monthly anniversaries of the vesting commencement date.
Documents
Issuer
Arch Therapeutics, Inc.
CIK 0001537561
Entity typeoperating
IncorporatedNV
Related Parties
1- filerCIK 0001537561
Filing Metadata
- Form type
- 4
- Filed
- Feb 5, 7:00 PM ET
- Accepted
- Feb 6, 11:26 AM ET
- Size
- 7.2 KB